Company Filing History:
Years Active: 2008-2013
Title: Wei Liu: Innovator in Pharmaceutical Development
Introduction
Wei Liu is a prominent inventor based in Coquitlam, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of immune diseases and pain management. With a total of 4 patents to his name, Liu's work has the potential to impact many lives.
Latest Patents
Liu's latest patents include innovative compounds that address critical health issues. One of his notable inventions is the development of 1,2-diphenylethene derivatives for the treatment of immune diseases. This invention provides novel compounds and their pharmaceutically acceptable salts, along with a process for their production. These compounds serve as modulators of T-cells, neutrophils, macrophages, and their associated cytokines, making them valuable agents for treating immune, inflammatory, and autoimmune diseases. Another significant patent involves the use of isovaline for pain treatment. This invention offers a solution for managing acute and chronic pain syndromes, especially in cases where other drug therapies have limited efficacy or unacceptable toxicity.
Career Highlights
Throughout his career, Wei Liu has worked with reputable companies in the pharmaceutical industry. He has been associated with Welichem Biotech Inc. and Glaxo Group Limited, where he has contributed to various research and development projects. His expertise in pharmaceutical innovation has positioned him as a key player in the field.
Collaborations
Liu has collaborated with notable professionals in his field, including Genhui Chen and John M Webster. These collaborations have further enhanced his research and development efforts, leading to groundbreaking inventions.
Conclusion
Wei Liu's contributions to pharmaceutical innovation are noteworthy, particularly in the areas of immune disease treatment and pain management. His patents reflect a commitment to improving health outcomes through scientific advancement. Liu's work continues to inspire future innovations in the pharmaceutical industry.